Correction to: European Journal of Human Genetics https://doi.org/10.1038/s41431-021-00920-y, published online 15 July 2021
The Data statement was partly wrong and should have read as below.
DATA AVAILABILITY
All data and material are either included in the Supplementary information or publicly available (i.e., the published articles, PubMed). The guidelines and background information are available on the website of the Royal Dutch Pharmacists Association (KNMP) (Pharmacogenetic Recommendations. Available from: https://www.knmp.nl/). The guidelines and background information will be available on PharmGKB.org.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matic, M., Nijenhuis, M., Soree, B. et al. Correction: Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone). Eur J Hum Genet 30, 1196 (2022). https://doi.org/10.1038/s41431-021-00969-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41431-021-00969-9
This article is cited by
-
Knowledge, attitude and perception of community pharmacists towards pharmacogenomics services in northern Nigeria: a cross-sectional study
Journal of Pharmaceutical Policy and Practice (2022)
-
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2C19 and CYP2D6 and SSRIs
European Journal of Human Genetics (2021)
